Your resource for news about the clinical laboratory community! Check us out at https://xitter.cf/t.co/xKvoytrXJT.

Joined December 2018
Don't miss out on our free whitepaper resource: Conventional versus Convenience: Clinician Collected or At-Home Collected Testing for Sexually Transmitted Infections! Download the whitepaper here: bit.ly/48JIec0
2
171
Today, we honor and celebrate Dr. Martin Luther King, Jr. #mlk #mlkday #martinlutherkingjr #civilrights
1
57
馃巼 We wish you all a healthy and happy New Year! #happynewyear #newyear #newyearseve
1
1
2
79
Have you seen our coverage of #2022AACC? Check it out on our special microsite at bit.ly/3zO4odv. #diagnostics #testing
1
9
@quotient and @TheradiagSA are collaborating to advance autoimmune disease testing and will begin by focusing on connective tissue conditions. #autoimmune #connectivetissue buff.ly/3NAYIIk
Replying to @Proscia
@ProsciaInc has obtained the CE Mark under IVDR, the new European in vitro diagnostic regulation, for use of its Concentriq Dx digital pathology platform in primary diagnosis. #pathology #ArtificialIntelligence buff.ly/3xCGdOl
1
Replying to @CerTestBiotec
@CerTestBiotec and @BDandCo have announced that they will develop a molecular diagnostic test for the monkeypox virus. #MonkeypoxVirus #diagnostics #testing buff.ly/3xkGmVe
Replying to @QuestDX
@QuestDX said this week that demand and positivity rose steadily throughout May for its COVID-19 molecular diagnostic testing but slowed toward the end of the month. #COVID19 #diagnostics #testing buff.ly/3QfvWyD
Replying to @QuestDX
@QuestDX said that both demand and positivity rose steadily throughout May for its COVID-19 molecular diagnostic testing, but the pace of demand and positivity moderated toward the end of the month. #COVID19 #diagnostics #testing buff.ly/3O0K90A
Grail announced a presentation at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago describing a study design for its Galleri multicancer early detection (MCED) blood test. @GrailBio. #liquidbiopsy. buff.ly/3xbiiUC